Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #8,501 to #8,550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Oxyphil cell (parathyroid) (1 revision)
  2. Oxytetracycline hydrochloride adverse reactions (1 revision)
  3. Oxytetracycline hydrochloride contraindications (1 revision)
  4. Oxytetracycline hydrochloride dosage and administration (1 revision)
  5. Oxytetracycline hydrochloride how supplied (1 revision)
  6. Oxytetracycline hydrochloride indications and usage (1 revision)
  7. Oxytetracycline hydrochloride warnings and precautions (1 revision)
  8. Oxytocin injection (patient information) (1 revision)
  9. Oxyurida (1 revision)
  10. Oyster plant (1 revision)
  11. Ozanimod (1 revision)
  12. Ozone (1 revision)
  13. Ozonide (1 revision)
  14. P-block (1 revision)
  15. P-selectin glycoprotein ligand-1 (1 revision)
  16. P11 protein (1 revision)
  17. P2RY5 (1 revision)
  18. P2X Receptor (1 revision)
  19. P2X receptor (1 revision)
  20. P53 (1 revision)
  21. P57 (glycoside) (1 revision)
  22. PA (1 revision)
  23. PAAF1 (1 revision)
  24. PABPC4L (1 revision)
  25. PAFAH1B2 (1 revision)
  26. PAFAH1B3 (1 revision)
  27. PAFAH2 (1 revision)
  28. PAIP1 (1 revision)
  29. PAK1IP1 (1 revision)
  30. PAK7 (1 revision)
  31. PALLAS trial (1 revision)
  32. PALLD (1 revision)
  33. PAN3 (1 revision)
  34. PANDAS (1 revision)
  35. PANK4 (1 revision)
  36. PAPB (1 revision)
  37. PAPLN (1 revision)
  38. PAQR7 (1 revision)
  39. PAQR8 (1 revision)
  40. PAQR9 (1 revision)
  41. PAR1 (gene) (1 revision)
  42. PARC (gene) (1 revision)
  43. PARD6B (1 revision)
  44. PARGY-LAD (1 revision)
  45. PARK11 (1 revision)
  46. PARL (1 revision)
  47. PARN (1 revision)
  48. PARP12 (1 revision)
  49. PARP16 (1 revision)
  50. PARSIFAL study (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)